Chattem, Inc., in September 2008, resolved all Dexatrim cases
pending against it for US$13,250,000 of which US$2,545,000 was
funded from the proceeds of the Dexatrim settlement trust.
The Company is not currently aware of any additional product
liability claims relating to…